Last reviewed · How we verify

NCT06182007

Post-Resuscitation Pneumothorax - Analysis of Incidence, Risk Factors and Outcome Relevance

Completed Last updated 26 December 2023
What this trial tests

trial testing Cardiopulmonary Resuscitation in Cardiac Arrest in 237 participants. Completed in 31 December 2022.

Timeline
2 February 2020
Primary endpoint
20 October 2022
31 December 2022

Quick facts

Lead sponsorAuinger, Daniel MD
StatusCompleted
Study typeOBSERVATIONAL
Enrollment237
Start date2 February 2020
Primary completion20 October 2022
Estimated completion31 December 2022
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Auinger, Daniel MD

Who can join

18 and older, any sex, with Cardiac Arrest or Pneumothorax. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this retrospective study, the investigators seek to investigate the incidence of pneumothorax following possible risk factors, and elucidate its association with outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Post-resuscitation pneumothorax: retrospective analysis of incidence, risk factors and outcome-relevance.
    Auinger D, Hötzer D, Zajic P, Orlob S, et al · · 2024 · cited 2× · PMID 39238051 · DOI 10.1186/s13049-024-01260-8

Verify or expand the search:

Other trials of Cardiopulmonary Resuscitation

Trials testing the same drug.

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06182007.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing